Dexcom Reports Third Quarter 2026 Financial Results
Revenue$1.344 billion+11% YoY
Outlookraisedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.